📰 Recursion Pharmaceuticals News
Page 13 - Recursion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recursion Pharmaceuticals. Real-time updates on events, politics, business and more.
February 14, 2024
(Bloomberg) -- Nvidia Corp., the chipmaker at the heart of an artificial intelligence spending boom, disclosed investments in Arm Holdings Plc, SoundHound AI Inc. and the biotech company Recursion Pharmaceuticals Inc.Most Read from BloombergThe Brutal Reality of Plunging Office Values Is HereDip Buyers Wade Back In to Fuel Wall Street Gains: Markets WrapIsrael Pulls Out of Peace Talks Over ‘Delusional’ Hamas DemandsLyft’s CEO Says ‘My Bad’ on Margin Error, ...
February 8, 2024
These two platform biotechs could revolutionize the field of biologically based products.
February 8, 2024
These two platform biotechs could revolutionize the field of biologically based products.
February 8, 2024
These two platform biotechs could revolutionize the field of biologically based products.
February 7, 2024
They aren't all long shots, but they're all innovative.
February 1, 2024
Wealthspire Advisors LLC bought a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 11,327 shares of the company’s stock, valued at approximately $87,000. Other institutional investors and hedge funds have […]
January 30, 2024
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 8,000 shares of Recursion Pharmaceuticals stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $10.35, for a total transaction of $82,800.00. Following the sale, the chief operating officer now owns 414,548 shares […]
January 30, 2024
In this article, we will look at 20 countries with the highest life expectancy in the world.
January 28, 2024
It's also important to consider their downsides.
January 25, 2024
The widely followed growth stock investor is adding to some of her holdings this week.